Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Sockel

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Leukemia|July 7, 2023
Activation of distinct inflammatory pathways in subgroups of LR-MDSMarie Schneider, Clara Rolfs, Matthias Trumpp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)Nicolaus Kröger, Katja Sockel, Christine Wolschke, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
NPJ Precision Oncology|December 11, 2025
Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasiaJan-Niklas Eckardt, Ishan Srivastava, Freya Schulze, et al.
Leukemia|March 13, 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines CommitteeDonal P McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Bone Marrow Transplantation|June 24, 2026
Integrated transcriptomic and TCR profiling reveals local immune dysregulation of T cells in Gl aGvHDManisha Goel, Anne Eugster, Susanne Reinhardt, et al.
Leukemia|April 17, 2024
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DR<sup>low/neg</sup> monocytes in lower-risk myelodysplastic neoplasmsSusann Winter, Marie Schneider, Uta Oelschlaegel, et al.
Leukemia|August 6, 2025
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblingsJohannes Schetelig, Henning Baldauf, Carina Rave, et al.
Transplantation and Cellular Therapy|June 16, 2026
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine OutcomeAnnemarie Mohring, Katja Sockel, Christian Thiede, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2017
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE TrialJan Moritz Middeke, Regina Herbst, Stefani Parmentier, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Leukemia|July 7, 2023
Activation of distinct inflammatory pathways in subgroups of LR-MDSMarie Schneider, Clara Rolfs, Matthias Trumpp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)Nicolaus Kröger, Katja Sockel, Christine Wolschke, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
NPJ Precision Oncology|December 11, 2025
Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasiaJan-Niklas Eckardt, Ishan Srivastava, Freya Schulze, et al.
Leukemia|March 13, 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines CommitteeDonal P McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Bone Marrow Transplantation|June 24, 2026
Integrated transcriptomic and TCR profiling reveals local immune dysregulation of T cells in Gl aGvHDManisha Goel, Anne Eugster, Susanne Reinhardt, et al.
Leukemia|April 17, 2024
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DR<sup>low/neg</sup> monocytes in lower-risk myelodysplastic neoplasmsSusann Winter, Marie Schneider, Uta Oelschlaegel, et al.
Leukemia|August 6, 2025
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblingsJohannes Schetelig, Henning Baldauf, Carina Rave, et al.
Transplantation and Cellular Therapy|June 16, 2026
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine OutcomeAnnemarie Mohring, Katja Sockel, Christian Thiede, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2017
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE TrialJan Moritz Middeke, Regina Herbst, Stefani Parmentier, et al.
Pageof 10